GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,638,000 | -40.9% | 151,800 | +60.1% | 0.37% | -40.2% |
Q4 2021 | $2,771,000 | +399.3% | 94,800 | +334.9% | 0.62% | +360.4% |
Q3 2021 | $555,000 | -27.3% | 21,800 | 0.0% | 0.13% | -33.3% |
Q2 2021 | $763,000 | -14.1% | 21,800 | 0.0% | 0.20% | -14.5% |
Q1 2021 | $888,000 | -5.9% | 21,800 | 0.0% | 0.24% | -8.9% |
Q4 2020 | $944,000 | -21.5% | 21,800 | 0.0% | 0.26% | -33.5% |
Q3 2020 | $1,202,000 | +84.4% | 21,800 | +122.4% | 0.39% | +78.8% |
Q2 2020 | $652,000 | +30.9% | 9,800 | 0.0% | 0.22% | -4.4% |
Q1 2020 | $498,000 | -72.9% | 9,800 | -57.6% | 0.23% | -65.7% |
Q4 2019 | $1,836,000 | +104.7% | 23,100 | +24.9% | 0.66% | +59.3% |
Q3 2019 | $897,000 | -39.1% | 18,500 | -33.9% | 0.42% | -24.0% |
Q2 2019 | $1,472,000 | -0.6% | 28,000 | 0.0% | 0.55% | -0.2% |
Q1 2019 | $1,481,000 | +164.0% | 28,000 | +36.6% | 0.55% | +156.8% |
Q2 2017 | $561,000 | -73.7% | 20,500 | -64.7% | 0.21% | -73.9% |
Q1 2017 | $2,134,000 | – | 58,000 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |